fingolimod hydrochloride has been researched along with Cardiovascular Stroke in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Alatrag, F; Amoni, M; Gwanyanya, A; Kelly-Laubscher, R | 1 |
| Ching, D; Eberlé, D; Honbo, N; Imhof, I; Karliner, JS; Kim, RY; Kumar, N; Li, K; Luk, FS; Raffai, RL; Wang, G; Zhu, BQ | 1 |
| Büttner, R; Diehl, L; Goltz, D; Huss, S; Meyer, R; Ramadori, E | 1 |
| Ching, D; Honbo, N; Hoover, H; Imhof, I; Joshi, SK; Karliner, JS; Kim, RY; Li, K; Lovett, DH; Luk, FS; Raffai, RL; Wong, DK; Zhu, BQ | 1 |
| Gao, E; He, Y; Lee, Y; Tao, L; Wang, W; Xia, Y; Xin, C; Yan, W; Zhang, F; Zhang, H; Zhang, L; Zhao, S; Zhou, F; Zhu, D | 1 |
| Arias, T; Badimon, JJ; Fuster, V; Goliasch, G; Hajjar, RJ; Ishikawa, K; Narula, J; Njerve, IU; Picatoste, B; Santos-Gallego, CG; Sanz, J; Sengupta, PP; Vahl, TP | 1 |
| Altara, R; Booz, GW; Eid, A; Kaplan, A; Zouein, FA | 1 |
| Bauersachs, J; Bonz, A; Burkard, N; Ertl, G; Frantz, S; Hofmann, U; Hu, K; Ritter, O; Walter, F | 1 |
1 review(s) available for fingolimod hydrochloride and Cardiovascular Stroke
| Article | Year |
|---|---|
Update on the Protective Role of Regulatory T Cells in Myocardial Infarction: A Promising Therapy to Repair the Heart.
Topics: Animals; CD28 Antigens; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Myocardial Infarction; Myocardial Reperfusion Injury; T-Lymphocytes, Regulatory; Ventricular Remodeling | 2016 |
7 other study(ies) available for fingolimod hydrochloride and Cardiovascular Stroke
| Article | Year |
|---|---|
Cardioprotective effect of fingolimod against calcium paradox-induced myocardial injury in the isolated rat heart.
Topics: Animals; Calcium; Cardiotonic Agents; Fingolimod Hydrochloride; In Vitro Techniques; Magnesium; Male; Masoprocol; Myocardial Infarction; Rats, Wistar; TRPM Cation Channels | 2022 |
The immunosuppressant FTY720 prolongs survival in a mouse model of diet-induced coronary atherosclerosis and myocardial infarction.
Topics: Animals; Apolipoproteins E; Cardiotonic Agents; Coronary Artery Disease; Diet, High-Fat; Disease Models, Animal; Fingolimod Hydrochloride; Immunosuppressive Agents; Inflammation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Myocardial Reperfusion Injury; Propylene Glycols; Sphingosine; Survival Rate; T-Lymphocytes, Regulatory; Time Factors; Transforming Growth Factor beta; Ventricular Function, Left | 2014 |
Immunomodulation by splenectomy or by FTY720 protects the heart against ischemia reperfusion injury.
Topics: Animals; Chemotaxis; Cytoprotection; Disease Models, Animal; Fingolimod Hydrochloride; Hemodynamics; Immunity, Innate; Immunosuppressive Agents; Male; Mice, Inbred C57BL; Monocytes; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Phagocytosis; Splenectomy; Time Factors | 2015 |
Immunosuppression With FTY720 Reverses Cardiac Dysfunction in Hypomorphic ApoE Mice Deficient in SR-BI Expression That Survive Myocardial Infarction Caused by Coronary Atherosclerosis.
Topics: Animals; Apolipoproteins E; Coronary Artery Disease; Diet, High-Fat; Fingolimod Hydrochloride; Gene Expression Regulation; Immunosuppressive Agents; Mice; Mice, Transgenic; Myocardial Infarction; Scavenger Receptors, Class B; Survival Rate | 2016 |
Sphingosine 1-phosphate signaling contributes to cardiac inflammation, dysfunction, and remodeling following myocardial infarction.
Topics: Animals; Animals, Newborn; Cytokines; Fingolimod Hydrochloride; Heart Diseases; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocarditis; Myocytes, Cardiac; Phosphotransferases (Alcohol Group Acceptor); Rats, Sprague-Dawley; Receptors, Lysosphingolipid; RNA, Small Interfering; Signal Transduction; Sphingosine; Sphingosine-1-Phosphate Receptors; Transfection; Ultrasonography | 2016 |
Sphingosine-1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Porcine Model of Ischemia/Reperfusion.
Topics: Animals; Disease Models, Animal; Fingolimod Hydrochloride; Myocardial Infarction; Myocardial Reperfusion Injury; Receptors, Lysosphingolipid; Salvage Therapy; Swine; Ventricular Remodeling | 2016 |
Pharmacological pre- and post-conditioning with the sphingosine-1-phosphate receptor modulator FTY720 after myocardial ischaemia-reperfusion.
Topics: Animals; Arrhythmias, Cardiac; Calcium; Disease Models, Animal; Down-Regulation; Fingolimod Hydrochloride; Ischemic Preconditioning, Myocardial; Lymphocyte Count; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Propylene Glycols; Rats; Rats, Wistar; Receptors, Lysosphingolipid; Sphingosine; Tumor Necrosis Factor-alpha | 2010 |